A detailed history of Beverly Hills Private Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Beverly Hills Private Wealth, LLC holds 13,397 shares of ABBV stock, worth $3.13 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
13,397
Previous 13,781 2.79%
Holding current value
$3.13 Million
Previous $2.56 Billion 21.27%
% of portfolio
0.55%
Previous 0.48%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

SELL
$184.85 - $231.54 $70,982 - $88,911
-384 Reduced 2.79%
13,397 $3.1 Billion
Q2 2025

Jul 29, 2025

BUY
$170.16 - $206.27 $11,060 - $13,407
65 Added 0.47%
13,781 $2.56 Billion
Q1 2025

Apr 29, 2025

SELL
$169.2 - $216.66 $171,907 - $220,126
-1,016 Reduced 6.9%
13,716 $2.87 Billion
Q4 2024

Feb 13, 2025

BUY
$164.99 - $203.87 $47,847 - $59,122
290 Added 2.01%
14,732 $2.62 Billion
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $246,906 - $300,390
-1,507 Reduced 9.45%
14,442 $2.85 Billion
Q2 2024

Aug 07, 2024

SELL
$154.79 - $180.76 $152,622 - $178,229
-986 Reduced 5.82%
15,949 $2.74 Billion
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $203,450 - $231,813
-1,273 Reduced 6.99%
16,935 $3.08 Billion
Q4 2023

Jan 29, 2024

SELL
$137.6 - $154.97 $45,545 - $51,295
-331 Reduced 1.79%
18,208 $2.82 Billion
Q3 2023

Nov 08, 2023

SELL
$133.59 - $154.65 $2.19 Million - $2.53 Million
-16,386 Reduced 46.92%
18,539 $2.76 Billion
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $2.25 Million - $2.79 Million
16,948 Added 94.28%
34,925 $5.16 Billion
Q1 2023

May 03, 2023

BUY
$144.61 - $166.54 $420,959 - $484,797
2,911 Added 19.32%
17,977 $2.86 Billion
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $2.08 Million - $2.5 Million
15,066 New
15,066 $2.43 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Beverly Hills Private Wealth, LLC Portfolio

Follow Beverly Hills Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beverly Hills Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beverly Hills Private Wealth, LLC with notifications on news.